New Hampshire Clinical Trials Report — June 2026

For New Hampshire residents considering participation in clinical research, June 2026 presents a critical window to act, particularly for studies nearing their enrollment deadlines. A total of 18 clinical trials across the state are slated to close within the next 90 days, meaning time is running out to explore these opportunities. Among these, 4 trials are actively seeking healthy volunteers, offering a chance to contribute to medical science without a specific health condition.

Individuals living with certain health conditions should also act quickly to explore trials with impending deadlines. Research focusing on various conditions, from cancer to heart health and mental well-being, are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Breast cancer (3 trials)
• Trauma injury (2 trials)
• Alcohol consumption
• Atopic dermatitis
• Atrial fibrillation
• Bleeding
• Cannabis use
• Anxiety
• Chronic granulomatous disease (CGD)
• Congenital heart disease

If you or someone you know is affected by these conditions, investigating these trials promptly could provide access to new treatment approaches or diagnostic methods before enrollment closes.

Innovative Research Launches in New Hampshire

This month, New Hampshire welcomes 2 new clinical trials. While this number is lower compared to the 6 trials that opened in May 2026, and represents a dip in the 6-month trend (which saw a peak of 8 new trials in February), the new studies bring important advancements, particularly in device technology and public health research.

A notable new study is sponsored by Castle Biosciences Incorporated, focusing on a non-invasive approach to managing a common skin condition:

• NCT07645820: "Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares." This industry-sponsored study is designed to evaluate the Nevisense Go device, which aims to provide early detection of atopic dermatitis (AD) flares. Participants, aged 12 to 89 years with a history of AD flares, will use this investigational device at home for approximately 90 days. The study involves collecting skin measurements and completing electronic diary entries. This type of device trial offers a convenient way for participants to contribute to research from their own homes, potentially leading to better management tools for AD.

The other new trial this month, sponsored by the Trustees of Dartmouth College, addresses a critical public health area:

• A study focusing on perinatal substance use. This academic-led research contributes to understanding and supporting individuals during a vulnerable period, highlighting the state's commitment to comprehensive health initiatives.

Both new trials include older adults in their eligibility criteria, and one specifically includes children, ensuring that research benefits a broad range of age groups within the New Hampshire community.

Healthy Volunteer Opportunities and Broader Participation

For individuals without a specific medical condition, opportunities to contribute to medical science are available, though none of the 2 new trials this month are seeking healthy volunteers. However, statewide, a total of 28 clinical trials are currently recruiting healthy participants. As mentioned, 4 of these healthy volunteer trials are closing within the next 90 days, so interested individuals should explore these options without delay.

New Hampshire's clinical research landscape is designed to be inclusive, with a broad range of eligibility criteria. Of the new trials, 1 includes children as participants, and both new trials include older adults, ensuring that research benefits diverse age groups. Academic institutions, like the Trustees of Dartmouth College, and industry sponsors, such as Castle Biosciences Incorporated, are both driving significant research efforts in the state.

Geographic Reach: Expanding Access Across the Granite State

New Hampshire's clinical research efforts are spread across the state, with 322 clinical trials currently recruiting in 20 cities and at 110 research sites. This broad distribution ensures that residents in various regions have access to cutting-edge research opportunities.

This month, the 2 new research initiatives are located in:

• Lebanon (1 new trial)
• Portsmouth (1 new trial)

While these cities host the newest studies, the overall distribution of trials across the state means that individuals in many communities can find research sites within a reasonable distance. This accessibility is crucial for fostering broad participation in clinical trials, allowing more New Hampshirites to contribute to and benefit from medical advancements.

As we move into the summer months, the focus will remain on the ongoing enrollment in these important studies, particularly those nearing their conclusion, and the continued exploration of new treatments, diagnostics, and preventive measures for a broad spectrum of health challenges across New Hampshire.